PRT543, a protein arginine methyltransferase 5 inhibitor, in patients with advanced adenoid cystic carcinoma: An open-label, phase I dose-expansion study

Renata Ferrarotto, Paul L. Swiecicki, Dan P. Zandberg, Robert A. Baiocchi, Robert Wesolowski, Cristina P. Rodriguez, Meredith McKean, Hyunseok Kang, Varun Monga, Rajneesh Nath, Neil Palmisiano, Naveen Babbar, William Sun, Glenn J. Hanna

DOI: 10.1016/j.oraloncology.2023.106634